AI for Pharmacists in 2026: From the Phone Queue to Final Check

AI can now answer refill calls, sort faxed prescriptions, draft replies to drug questions and photograph what's in the vial. It can't decide whether a DUR alert matters for this patient, hold your corresponding responsibility on a controlled substance, or counsel someone who is frightened of a new diagnosis. Those stay with the pharmacist.

Most writing on this topic talks about pharmacy AI in general, or guesses how many decades your job has left. This page walks a prescription's path stop by stop, names real products at each one, and says what the evidence and the rules show. Vendor numbers are labeled as vendor numbers.

Where a pharmacist's day goes besides the final check

Pharmacist work is split between clinical judgment and the admin wrapped around it. Federal labor data counts about 325,200 pharmacist jobs, with 37% in pharmacies and drug retailers and 32% in hospitals, and lists insurer billing problems, technician supervision and record keeping next to dispensing and vaccinating (BLS). O*NET's task list adds resolving billing with insurers, ordering stock and troubleshooting pharmacy databases (O*NET).

You know how that feels on a Monday: a voicemail box full of refill requests, a claim rejected with a PA required, a wholesaler short on an injectable, and a prescriber's office that hasn't called back. Much of the AI sold to pharmacies today goes after those interruptions rather than your clinical check.

What AI can do at each stop on a prescription's path

Pharmacy AI products sit at specific points in the workflow, and most depend on your pharmacy management system (PMS) or your employer's contract. Check PMS compatibility before you compare anything else.

The phone queue is the easiest handoff

Refill and status calls are a sensible first task for pharmacy AI because the script is short and the clinical line is easy to draw. VOXO says its agent handles refills, status checks, hours and basic insurance questions, sends clinical calls to staff with context, and has guardrails for controlled substances and early refills (VOXO). It also reports more than 1.2 million calls and 316,000 refill requests submitted on its own, with direct links into PioneerRx and Liberty (VOXO's own figures). Its product page lists no price.

Before signing with any voice vendor, try to break the agent during the demo. Say you doubled your dose yesterday. Ask for an early oxycodone refill because you're traveling. Ask if your new antibiotic is okay with your birth control. Each of those should reach a person fast. VOXO's own page tells buyers to ask vendors whether they will sign a business associate agreement, which is the right question, so ask it in writing.

Faxes, e-scripts and PA rejections

Intake automation is real but tied to specific systems. RedSail says SmartFax uses OCR and document processing to sort faxes, send prescriptions to the fill queue and attach them to a patient profile, with confidence scoring, and it currently integrates only with PioneerRx (RedSail). In May 2025 PioneerRx also said a Data Entry Agent that reads eScripts and submits claims was on the way (PioneerRx). Ask your rep whether it's live on your version.

On prior authorization, faster doesn't always mean AI. CoverMyMeds' IntelligentPA, as integrated with ScriptPro, auto-fills the form from claim data and starts the request when the claim rejects (ComputerTalk). Upstream, Surescripts checks chart data against PBM criteria when the prescriber signs, approves matches instantly and marks the rest "insufficient evidence," and its chief medical information officer says the automation does not use AI (Managed Healthcare Executive). Its reported approval rate is 34%, and everything else falls back to the prescriber's earlier process, so rejected claims can keep reaching your counter.

Drug questions: useful drafts, weak references

General chatbots have a poor record on drug information, and purpose-built tools do better without matching a pharmacist. When Long Island University researchers put 39 real drug information questions to free ChatGPT in 2022 and 2023, 10 answers were satisfactory, and every response that offered references included ones that don't exist. It also said no interaction had been reported between Paxlovid and verapamil, a pair that can drop blood pressure too far (study summary). Models have changed since, but the habit of checking shouldn't.

Newer comparisons favor tools built for clinicians. Pharmacy Times reports that OpenEvidence scored highest of five chatbots on 30 drug information questions (17.82 of 25, against 15.72 for ChatGPT), yet all five scored significantly below pharmacists' answers. In a separate test on long-acting injectable antipsychotic dosing, OpenEvidence reached 95% accuracy and ChatGPT 40%, with most errors in missed-dose scenarios (Pharmacy Times). Missed-dose questions are exactly what patients call about, so treat those answers as the riskiest.

Wolters Kluwer added about 3,000 Lexidrug drug topics, written and reviewed by pharmacists and clinical specialists, to UpToDate Expert AI in November 2025 (HLTH). If your hospital already licenses UpToDate, ask whether you have access before paying for something else.

The final check: imaging helps, your state decides the rest

Imaging tools can support the final check, but they don't define it. InterLink AI identRx images a fill and confirms brand, dose and count (PioneerRx), and Omnicell's IVX Station combines weight, barcode and image checks in the IV room (Omnicell). Whether any of that can stand in for part of a pharmacist's check depends on your state, so ask your board of pharmacy before changing how verification works.

Shortage prediction: promising, not proven

Shortage forecasting is the claim to discount most. ASHP counted 227 active shortages at the end of Q2 2026, and a pharmacist's analysis of about 3,000 drugs in Pharmacy Times found public data carries only a modest signal, with machine learning not clearly beating a simple scoring rule. Sterile injectables and controlled substances were among the higher-risk groups, and the author notes that spotting risk factors isn't the same as predicting when a shortage starts (Pharmacy Times). On the wholesale side, Cencora reports a 10% forecasting improvement in early results, on a limited set of SKUs and buyers (Pharmaceutical Commerce). Keep planning substitutions and prescriber calls as you do now, and ask any vendor for results on the products you actually stock.

What the rules keep with the pharmacist

Federal rules keep these duties with you or your pharmacy, whatever software you buy. All four are worth rereading before a vendor demo:

• Prospective DUR and the counseling offer. For Medicaid, pharmacists must screen each prescription for duplication, contraindications, interactions, incorrect dose or duration, allergies and misuse, offer to counsel, and document DUR activity under state guidelines (42 CFR 456.705). An AI alert can feed that review. Clearing it is your call.
• Controlled substances. The prescriber writes the order, but "a corresponding responsibility rests with the pharmacist who fills the prescription" (21 CFR 1306.04). A confident risk score doesn't discharge that.
• Patient data. A vendor handling PHI for your pharmacy has to give satisfactory assurances, documented in a written contract or similar agreement (45 CFR 164.502(e)). OpenEvidence, for example, says PHI entered by a covered entity falls under its BAA and that users stay responsible for their inputs (OpenEvidence). With no signed agreement, keep names, dates of birth and Rx numbers out of the prompt.
• Medicare MTM. Part D comprehensive medication reviews need a real-time conversation with a pharmacist or other qualified provider, and the written summary follows a format CMS specifies (42 CFR 423.153). AI can tidy the paperwork, but it can't be the interactive part.

State boards are starting to write this down. New Hampshire's Board of Pharmacy is considering rules, still under development as of an October 2026 law firm summary, that would bar AI from being the sole basis for verification, dispensing or overriding significant alerts without review. Pharmacies would also document each tool's intended use and review triggers, keep records of who accepted or overrode a recommendation for at least four years, and stay responsible for vendors (Quarles & Brady). That's a draft from one state, but it's a good checklist anywhere. Ask your own board before changing how final verification works, and treat this page as background rather than legal advice.

Where Merlin fits: the pharmacy's relationships, not its patients

Merlin, the Mac assistant from the team behind this page, has no place at the bench. It doesn't connect to a PMS, answer the pharmacy phone, check interactions or touch a claim, and it can't place phone calls at all. Its privacy policy and terms don't mention HIPAA or a BAA, so don't use it with PHI. It reads the mail and calendar of whichever Google account you connect, including in the background, and on paid plans sends call audio for transcription, with transcripts stored on your Merlin account. Connect only an account with no patient mail and no patient names on the calendar. If your chain or health system controls your email, this probably isn't for that account.

That leaves owners, managers and clinical leads with a business inbox on a Mac. The useful parts:

• The people you can't afford to lose track of. When a wholesaler rep, PBM network contact or clinic manager emails you personally and you haven't answered after two days (it looks at a month of mail), Merlin lists them under Needs you. Someone you once emailed often moves to Gone quiet after two silent months, which helps with the prescriber's office you meant to visit about a collaborative practice agreement.
• Calls with no patient cases. Before a vendor demo or a meeting with a school's experiential coordinator, Meeting Brief sends a heads-up with context on who's attending. Merlin can record those calls, once everyone has agreed, and transcripts start with the $29 Pro plan (pricing). Afterward, Merlin may message you with what each side promised.
• Dates with a penalty attached. Ask for a reminder on license renewal, CE deadlines or a contract's notice window.
• Your sign-off on outgoing mail. Have Merlin write back to a rep from chat, and the draft waits on screen until you press Send. Routines, Merlin's scheduled background jobs, happen with nobody there to press it, so use one for a Monday list of open items and do the sending yourself.

Five steps before your pharmacy buys anything

1. Count one week of interruptions. Tally calls by type, PA rejections and faxes on paper. The largest pile tells you what to shop for, and it gives you a baseline no brochure can.
2. Ask your PMS vendor first. Find out which AI features are live on your version, which cost extra, and which third parties connect directly.
3. Get the BAA before the demo goes further. No signed agreement, no real patient data. Test with made-up scenarios.
4. Run a drug information check of your own. Take ten questions you've already answered, including two missed-dose questions, and grade a tool's answers against your reference. Open every citation.
5. Write the review rule down. List who reviews each AI output, when a call or alert must reach a pharmacist, and how an override gets recorded. New Hampshire's draft is a fair template.

Before connecting any tool to your email, use our guide to checking which apps can reach your Google account. Our roundup of meeting note tools covers staff meetings and vendor calls.